289
Views
2
CrossRef citations to date
0
Altmetric
Studies in Humans

Supplementation with [6S]-5-methyltetrahydrofolate or folic acid equally reduces serum homocysteine concentrations in older adults

, , &
Pages 64-73 | Received 15 Dec 2016, Accepted 14 Apr 2017, Published online: 02 May 2017

References

  • Akoglu B, Schrott M, Bolouri H, Jaffari A, Kutschera E, Caspary WF, Faust D. 2008. The folic acid metabolite L-5-methyltetrahydrofolate effectively reduces total serum homocysteine level in orthotopic liver transplant recipients: a double-blind placebo-controlled study. Eur J Clin Nutr. 62:796–801.
  • Arruda VR, Siqueira LH, Goncalves MS, von Zuben PM, Soares MCP, Menezes R, Annichino-Bizzacchi JM, Costa FF. 1998. Prevalence of the mutation C677 -> T in the methylene tetrahydrofolate reductase gene among distinct ethnic groups in Brazil. Am J Med Genet. 78:332–335.
  • Balk EM, Raman G, Tatsioni A, Chung M, Lau J, Rosenberg IH. 2007. Vitamin B6, B12, and folic acid supplementation and cognitive function: a systematic review of randomized trials. Arch Intern Med. 167:21–30.
  • Bazzano LA. 2011. No effect of folic acid supplementation on cardiovascular events, cancer or mortality after 5 years in people at increased cardiovascular risk, although homocysteine levels are reduced. Evid Based Med. 16:117–118.
  • Bostom AG, Jacques PF, Liaugaudas G, Rogers G, Rosenberg IH, Selhub J. 2002. Total homocysteine lowering treatment among coronary artery disease patients in the era of folic acid-fortified cereal grain flour. Arterioscler Thromb Vasc Biol. 22:488–491.
  • Bostom AG, Shemin D, Bagley P, Massy ZA, Zanabli A, Christopher K, Spiegel P, Jacques PF, Dworkin L, Selhub J. 2000. Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients. Circulation. 101:2829–2832.
  • Curro M, Gugliandolo A, Gangemi C, Risitano R, Ientile R, Caccamo D. 2014. Toxic effects of mildly elevated homocysteine concentrations in neuronal-like cells. Neurochem Res. 39:1485–1495.
  • De Jager CA. 2014. Critical levels of brain atrophy associated with homocysteine and cognitive decline. Neurobiol Aging. 35:S35–S39.
  • De Meer K, Smulders YM, Dainty JR, Smith DE, Kok RM, Stehouwer CD, Finglas PM, Jakobs C. 2005. [6S]5-methyltetrahydrofolate or folic acid supplementation and absorption and initial elimination of folate in young and middle-aged adults. Eur J Clin Nutr. 59:1409–1416.
  • Durga J, van Boxtel MP, Schouten EG, Kok FJ, Jolles J, Katan MB, Verhoef P. 2007. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet. 369:208–216.
  • EFSA Panel on Food Additives, Nutrient Sources Added to Food. 2004. Opinion of the scientific panel on food additives, flavourings, processing aids and materials in contact with food (AFC) related to calcium L-methylfolate. EFSA J. 2:135.
  • Essouma M, Noubiap JJN. 2015. Therapeutic potential of folic acid supplementation for cardiovascular disease prevention through homocysteine lowering and blockade in rheumatoid arthritis patients. Biomark Res. 3:24.
  • Fohr IP, Prinz-Langenohl R, Bronstrup A, Bohlmann AM, Nau H, Berthold HK, Pietrzik K. 2002. 5,10-Methylenetetrahydrofolate reductase genotype determines the plasma homocysteine-lowering effect of supplementation with 5-methyltetrahydrofolate or folic acid in healthy young women. Am J Clin Nutr. 75:275–282.
  • Food and Nutrition Board, IOM. 1998. Dietary reference intakes for thiamine, riboflavin, niacin, vitamin B6, folate, vitamin B12, panthotenic acid, biotin, and choline. A report of the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate, Other B Vitamins, and Choline. National Academy Press, Washington.
  • Ganguly P, Alam SF. 2015. Role of homocysteine in the development of cardiovascular disease. Nutr J. 14:6.
  • Homocysteine Lowering Trialists C. 2005. Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr. 82:806–812.
  • Houghton LA, Sherwood KL, Pawlosky R, Ito S, O’Connor DL. 2006. [6S]-5-Methyltetrahydrofolate is at least as effective as folic acid in preventing a decline in blood folate concentrations during lactation. Am J Clin Nutr. 83:842–850.
  • Kunachowicz H, Przygoda B, Iwanow K, Nadolna I. 2005. Polish food composition tables. Warsaw: PZWL Press.
  • Lamers Y, Prinz-Langenohl R, Bramswig S, Pietrzik K. 2006. Red blood cell folate concentrations increase more after supplementation with [6S]-5-methyltetrahydrofolate than with folic acid in women of childbearing age. Am J Clin Nutr. 84:156–161.
  • Lamers Y, Prinz-Langenohl R, Moser R, Pietrzik K. 2004. Supplementation with [6S]-5-methyltetrahydrofolate or folic acid equally reduces plasma total homocysteine concentrations in healthy women. Am J Clin Nutr. 79:473–478.
  • Li Y, Huang T, Zheng Y, Muka T, Troup J, Hu FB. 2016. Folic acid supplementation and the risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. J Am Heart Assoc. 5:e003768.
  • Litynski P, Loehrer F, Linder L, Todesco L, Fowler B. 2002. Effect of low doses of 5-methyltetrahydrofolate and folic acid on plasma homocysteine in healthy subjects with or without the 677C->T polymorphism of methylenetetrahydrofolate reductase. Eur J Clin Invest. 32:662–668.
  • Ma F, Wu T, Zhao J, Han F, Marseglia A, Liu H, Huang G. 2016. Effects of 6-Month folic acid supplementation on cognitive function and blood biomarkers in mild cognitive impairment: a randomized controlled trial in China. J Gerontol A Biol Sci Med Sci. 71:1376–1383.
  • Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1215.
  • Muller H. 1995. [Intake of folic acid in the total daily diet–effect of food preparation on its folic acid content]. Z Lebensm Unters Forsch. 200:209–212.
  • Obeid R, Kirsch SH, Dilmann S, Klein C, Eckert R, Geisel J, Herrmann W. 2016. Folic acid causes higher prevalence of detectable unmetabolized folic acid in serum than B-complex: a randomized trial. Eur J Nutr. 55:1021–1028.
  • Pentieva K, McNulty H, Reichert R, Ward M, Strain JJ, McKillop DJ, McPartlin JM, Connolly E, Molloy A, Krämer K, Scott JM. 2004. The short-term bioavailabilities of [6S]-5-methyltetrahydrofolate and folic acid are equivalent in men. J Nutr. 134:580–585.
  • Petersen JF, Larsen BS, Sabbah M, Nielsen OW, Kumarathurai P, Sajadieh A. 2016. Long-term prognostic significance of homocysteine in middle-aged and elderly. Biomarkers. 21:490–496.
  • Pietruszka. 2007. The effectiveness of diet supplementation with folates relative to risk factors for folate deficiencies in young women. Warsaw: Warsaw Agricultural University Press.
  • Pietruszka B, Brzozowska A. 2014. Homocysteine serum level in relation to intake of folate, vitamins B12, B1, B2, and B6 and MTHFR c.665C→T polymorphism among young women. Austin J Nutri Food Sci. 2:1052–1059.
  • Prinz-Langenohl R, Bramswig S, Tobolski O, Smulders YM, Smith DEC, Finglas PM, Pietrzik K. 2009. [6S]-5-methyltetrahydrofolate increases plasma folate more effectively than folic acid in women with the homozygous or wild-type 677C -> T polymorphism of methylenetetrahydrofolate reductase. Br J Pharmacol. 158:2014–2021.
  • Prinz-Langenohl RLY, Moser R, Pietrzik K. 2004. Bioequivalence of [6S]-5-methyltetrahydrofolate and folic acid without and with folic acid preload in healthy volunteers. Warsaw: Warsaw Agricultural University Press.
  • Schorah CJ, Devitt H, Lucock M, Dowell AC. 1998. The responsiveness of plasma homocysteine to small increases in dietary folic acid: a primary care study. Eur J Clin Nutr. 52:407–411.
  • Selhub J. 2006. The many facets of hyperhomocysteinemia: studies from the Framingham cohorts. J Nutr. 136:1726S–1730s.
  • Selhub J, Rosenberg IH. 2016. Excessive folic acid intake and relation to adverse health outcome. Biochimie. 126:71–78.
  • Skovierova H, Vidomanova E, Mahmood S, Sopkova J, Drgova A, Cervenova T, Halasova E, Lehotsky J. 2016. The molecular and cellular effect of homocysteine metabolism imbalance on human health. Int J Mol Sci. 17:E1733.
  • Smith AD, Smith SM, de Jager CA, Whitbread P, Johnston C, Agacinski G, Oulhaj A, Oulhaj A, Bradley KM, Jacoby R, Refsum H. 2010. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS One. 5:e12244.
  • Sweeney MR, McPartlin J, Scott J. 2007. Folic acid fortification and public health: report on threshold doses above which unmetabolised folic acid appear in serum. BMC Public Health. 7:41.
  • Venn BJ, Green TJ, Moser R, Mann JI. 2003. Comparison of the effect of low-dose supplementation with L-5-methyltetrahydrofolate or folic acid on plasma homocysteine: a randomized placebo-controlled study. Am J Clin Nutr. 77:658–662.
  • Venn BJ, Green TJ, Moser R, Mckenzie JE, Skeaff CM, Mann J. 2002. Increases in blood folate indices are similar in women of childbearing age supplemented with [6S]-5-methyltetrahydrofolate and folic acid. J Nutr. 132:3353–3355.
  • Weir DG, Scott JM. 1999. Brain function in the elderly: role of vitamin B12 and folate. Br Med Bull. 55:669–682.
  • Wilcken B, Bamforth F, Li Z, Zhu H, Ritvanen A, Redlund M, Stoll C, Alembik Y, Dott B, Gelman-Kohan Z, et al. 2003. Geographical and ethnic variation of the 677C > T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. J Med Genet. 40:619–625.
  • Willems FF, Boers GHJ, Blom HJ, Aengevaeren WRM, Verheugt FWA. 2004. Pharmacokinetic study on the utilisation of 5-methyltetrahydrofolate and folic acid in patients with coronary artery disease. Br J Pharmacol. 141:825–830.
  • Wright AJA, King MJ, Wolfe CA, Powers HJ, Finglas PM. 2010. Comparison of (6S)-5-methyltetrahydrofolic acid v. folic acid as the reference folate in longer-term human dietary intervention studies assessing the relative bioavailability of natural food folates: comparative changes in folate status following a 16-week placebo-controlled study in healthy adults. Br J Nutr. 103:724–729.
  • Yang HT, Lee M, Hong KS, Ovbiagele B, Saver JL. 2012. Efficacy of folic acid supplementation in cardiovascular disease prevention: an updated meta-analysis of randomized controlled trials. Eur J Intern Med. 23:745–754.
  • Zappacosta B, Mastroiacovo P, Persichilli S, Pounis G, Ruggeri S, Minucci A, Carnovale E, Andria G, Ricci R, Scala I, et al. 2013. Homocysteine lowering by folate-rich diet or pharmacological supplementations in subjects with moderate hyperhomocysteinemia. Nutrients. 5:1531–1543.
  • Zhou YH, Tang JY, Wu MJ, Lu J, Wei X, Qin YY, Wang C, Xu JF, He J. 2011. Effect of folic acid supplementation on cardiovascular outcomes: a systematic review and meta-analysis. PLoS One. 6:e25142.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.